CYP2C9 and rheumatoid arthritis: The effect of the CYP2C9rs1799853 polymorphism on the risk of developing erosive disease in seropositive patients remained statistically significant after correction for multiple testing (P < 0.00074), which suggested a role of the CYP2C9 gene in modulating disease progression in RA.